Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models
Niranjan Awasthi(University of Notre Dame), Roderich E. Schwarz(Roswell Park Comprehensive Cancer Center), Changhua Zhang(Sun Yat-sen University), Quinn Kaurich(Indiana University South Bend), Margaret A. Schwarz(University of Notre Dame), Frank Hilberg(Boehringer Ingelheim (Germany))
Cited by 3
Related Papers
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
|Cancer Research|2008|1.1k
Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases
|Journal of Pharmacology and Experimental Therapeutics|2017|105
Associations of Mental Health and Personal Preventive Measure Compliance With Exposure to COVID-19 Information During Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study
|Journal of Medical Internet Research|2020|86
Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling
|Laboratory Investigation|2008|65